Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like ProSpection Solutions announced the PRO2300 CWI package inspection/weighing machine November 7, 2018 Rising rupee no barrier for India’s high-tech export machine May 12, 2017 Airbus Launches Strategic Review of Its Operations January 15, 2019